|
Aggarwal, B.B., Kumar, A. and Bharti, A.C. (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res, 23, 363-398. Alekshun, T. and Garrett, C. (2005) Targeted therapies in the treatment of colorectal cancers. Cancer Control, 12, 105-110. Aljada, A., Ghanim, H., Mohanty, P., Hofmeyer, D., Tripathy, D. and Dandona, P. (2001) Hydrocortisone suppresses intranuclear activator-protein-1 (AP-1) binding activity in mononuclear cells and plasma matrix metalloproteinase 2 and 9 (MMP-2 and MMP-9). J Clin Endocrinol Metab, 86, 5988-5991. Balkwill, F.R., Lee, A., Aldam, G., Moodie, E., Thomas, J.A., Tavernier, J. and Fiers, W. (1986) Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cancer Res, 46, 3990-3993. Barnes, R., Masood, S., Barker, E., Rosengard, A.M., Coggin, D.L., Crowell, T., King, C.R., Porter-Jordan, K., Wargotz, E.S., Liotta, L.A. and et al. (1991) Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Am J Pathol, 139, 245-250. Barriuso Feijoo, J., Sundlov, A. and Gonzalez Baron, M. (2004) [Antibodies against cancer]. Rev Clin Esp, 204, 649-654. Benbow, U., Schoenermark, M.P., Orndorff, K.A., Givan, A.L. and Brinckerhoff, C.E. (1999) Human breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by all-trans retinoic acid. Clin Exp Metastasis, 17, 231-238. Berg, P. and Joklik, W.K. (1953) Transphosphorylation between nucleoside polyphosphates. Nature, 172, 1008-1009. Berlin, J.D. (2002) Targeting vascular endothelial growth factor in colorectal cancer. Oncology (Huntingt), 16, 13-15. Bian, J. and Sun, Y. (1997) Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol, 17, 6330-6338. Biggs, J., Tripoulas, N., Hersperger, E., Dearolf, C. and Shearn, A. (1988) Analysis of the lethal interaction between the prune and Killer of prune mutations of Drosophila. Genes Dev, 2, 1333-1343. Bos, J.L. (1989) ras oncogenes in human cancer: a review. Cancer Res, 49, 4682-4689. Bouck, N. (1996) P53 and angiogenesis. Biochim Biophys Acta, 1287, 63-66. Bremnes, R.M., Veve, R., Hirsch, F.R. and Franklin, W.A. (2002) The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer, 36, 115-124. Brodie, A.H. and Mouridsen, H.T. (2003) Applicability of the intratumor aromatase preclinical model to predict clinical trial results with endocrine therapy. Am J Clin Oncol, 26, S17-26. Cao, L.Z. and Lin, Z.B. (2003) Regulatory effect of Ganoderma lucidum polysaccharides on cytotoxic T-lymphocytes induced by dendritic cells in vitro. Acta Pharmacol Sin, 24, 321-326. Cavallaro, U. and Christofori, G. (2001) Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim Biophys Acta, 1552, 39-45. Chambers, A.F., Groom, A.C. and MacDonald, I.C. (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer, 2, 563-572. Chang, C.C., Shih, J.Y., Jeng, Y.M., Su, J.L., Lin, B.Z., Chen, S.T., Chau, Y.P., Yang, P.C. and Kuo, M.L. (2004) Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J Natl Cancer Inst, 96, 364-375. Che, G.W., Zhou, Q.H., Zhu, W., Wang, Y.P., Qin, Y., Liu, L.X., Chen, X.H., Sun, Y.L. and Sun, Z.F. (2005) [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1]. Ai Zheng, 24, 278-284. Chen, H.Y., Chen, C.H., Yeh, M.Y., Wu, J.S., Yazama, K. and Mikami, Y. (1992) In vivo anti-candidal activity induced by tranditional Chinese herbal medicine, Ganoderma lucidium. Jpn. J. Med. Mycol., 33, 505-512. Chen, S.Y., Wang, X.Q., Li, X.M., Chen, Y.X. and Wu, C.Q. (2005a) [Expressions of P16 and nm23-H1 in nasopharyngeal cacinoma and their clinical significance]. Di Yi Jun Yi Da Xue Xue Bao, 25, 342-344, 348. Chen, X.F., Zhang, H.T., Qi, Q.Y., Sun, M.M. and Tao, L.Y. (2005b) Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China. Lung Cancer, 48, 69-76. Cheng, Y.C., Agarwal, R.P. and Parks, R.E., Jr. (1971) Erythrocytic nucleoside diphosphokinase. IV. Evidence for electrophoretic heterogeneity. Biochemistry, 10, 2139-2143. Cheng, Y.C., Robison, B. and Parks, R.E., Jr. (1973) Demonstration of the heterogeneity of nucleoside diphosphokinase in rat tissues. Biochemistry, 12, 5-10. Comer, K.A., Dennis, P.A., Armstrong, L., Catino, J.J., Kastan, M.B. and Kumar, C.C. (1998) Human smooth muscle alpha-actin gene is a transcriptional target of the p53 tumor suppressor protein. Oncogene, 16, 1299-1308. Conner, E.A., Teramoto, T., Wirth, P.J., Kiss, A., Garfield, S. and Thorgeirsson, S.S. (1999) HGF-mediated apoptosis via p53/bax-independent pathway activating JNK1. Carcinogenesis, 20, 583-590. Curran, S. and Murray, G.I. (2000) Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer, 36, 1621-1630. Dang, C.V. (1999) c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol, 19, 1-11. de la Rosa, A., Williams, R.L. and Steeg, P.S. (1995) Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. Bioessays, 17, 53-62. Dearolf, C.R., Hersperger, E. and Shearn, A. (1988) Developmental consequences of awdb3, a cell-autonomous lethal mutation of Drosophila induced by hybrid dysgenesis. Dev Biol, 129, 159-168. Demidenko, Z.N. and Blagosklonny, M.V. (2004) Flavopiridol induces p53 via initial inhibition of Mdm2 and p21 and, independently of p53, sensitizes apoptosis-reluctant cells to tumor necrosis factor. Cancer Res, 64, 3653-3660. Ellenrieder, V., Adler, G. and Gress, T.M. (1999) Invasion and metastasis in pancreatic cancer. Ann Oncol, 10 Suppl 4, 46-50. Ellis, L.M., Takahashi, Y., Liu, W. and Shaheen, R.M. (2000) Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Oncologist, 5 Suppl 1, 11-15. Falardeau, P., Champagne, P., Poyet, P., Hariton, C. and Dupont, E. (2001) Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials. Semin Oncol, 28, 620-625. Fang, L., Li, G., Liu, G., Lee, S.W. and Aaronson, S.A. (2001) p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. Embo J, 20, 1931-1939. Fischbach, M.A. and Settleman, J. (2003) Specific biochemical inactivation of oncogenic Ras proteins by nucleoside diphosphate kinase. Cancer Res, 63, 4089-4094. Florenes, V.A., Aamdal, S., Myklebost, O., Maelandsmo, G.M., Bruland, O.S. and Fodstad, O. (1992) Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res, 52, 6088-6091. Gardner, J. and Ghorpade, A. (2003) Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J Neurosci Res, 74, 801-806. Giatromanolaki, A. (2001) Prognostic role of angiogenesis in non-small cell lung cancer. Anticancer Res, 21, 4373-4382. Gomez, D.E., Alonso, D.F., Yoshiji, H. and Thorgeirsson, U.P. (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol, 74, 111-122. Greene, J., Wang, M., Liu, Y.E., Raymond, L.A., Rosen, C. and Shi, Y.E. (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem, 271, 30375-30380. Haak-Frendscho, M., Kino, K., Sone, T. and Jardieu, P. (1993) Ling Zhi-8: a novel T cell mitogen induces cytokine production and upregulation of ICAM-1 expression. Cell Immunol, 150, 101-113. Haffner, R. and Oren, M. (1995) Biochemical properties and biological effects of p53. Curr Opin Genet Dev, 5, 84-90. Hagemann, T., Robinson, S.C., Schulz, M., Trumper, L., Balkwill, F.R. and Binder, C. (2004) Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis, 25, 1543-1549. Hanahan, D. and Weinberg, R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70. Hartsough, M.T., Clare, S.E., Mair, M., Elkahloun, A.G., Sgroi, D., Osborne, C.K., Clark, G. and Steeg, P.S. (2001) Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Cancer Res, 61, 2320-2327. Hennessy, C., Henry, J.A., May, F.E., Westley, B.R., Angus, B. and Lennard, T.W. (1991) Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst, 83, 281-285. Hidalgo, M. and Eckhardt, S.G. (2001) Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst, 93, 178-193. Higashiyama, M., Doi, O., Yokouchi, H., Kodama, K., Nakamori, S., Tateishi, R. and Kimura, N. (1992) Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: lack of prognostic value. Br J Cancer, 66, 533-536. Hikino, H., Konno, C., Mirin, Y. and Hayashi, T. (1985) Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies. Planta Med, 339-340. Horner, W.E., Helbling, A. and Lehrer, S.B. (1993) Basidiomycete allergens: comparison of three Ganoderma species. Allergy, 48, 110-116. Howlett, A.R., Petersen, O.W., Steeg, P.S. and Bissell, M.J. (1994) A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J Natl Cancer Inst, 86, 1838-1844. Hsu, C.-i. (1996) Study on the Fungal Immunomodulatory Proteins. Department of Medical Technology, college of medicine. National Taiwan University, Taipei. Huebner, K., Isobe, M., Gasson, J.C., Golde, D.W. and Croce, C.M. (1986) Localization of the gene encoding human erythroid-potentiating activity to chromosome region Xp11.1----Xp11.4. Am J Hum Genet, 38, 819-826. Ingle, J.N. (2004) Sequencing of endocrine therapy in postmenopausal women with advanced breast cancer. Clin Cancer Res, 10, 362S-367S. Johnsen, M., Lund, L.R., Romer, J., Almholt, K. and Dano, K. (1998) Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol, 10, 667-671. Jorgensen, L.N. (2003) Collagen deposition in the subcutaneous tissue during wound healing in humans: a model evaluation. APMIS Suppl, 1-56. Kantor, J.D., McCormick, B., Steeg, P.S. and Zetter, B.R. (1993) Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res, 53, 1971-1973. Kao, Y.R., Shih, J.Y., Wen, W.C., Ko, Y.P., Chen, B.M., Chan, Y.L., Chu, Y.W., Yang, P.C., Wu, C.W. and Roffler, S.R. (2003) Tumor-associated antigen L6 and the invasion of human lung cancer cells. Clin Cancer Res, 9, 2807-2816. Katakura, H., Tanaka, F., Oyanagi, H., Miyahara, R., Yanagihara, K., Otake, Y. and Wada, H. (2002) Clinical significance of nm23 expression in resected pathologic-stage I, non-small cell lung cancer. Ann Thorac Surg, 73, 1060-1064. Kawagishi, H., Fukuhara, F., Sazuka, M., Kawashima, A., Mitsubori, T. and Tomita, T. (1993) 5''-Deoxy-5''-methylsulphinyladenosine, a platelet aggregation inhibitor from Ganoderma lucidium. Phytochemistry, 32, 239-241. Kawakubo, Y., Sato, Y., Koh, T., Kono, H. and Kameya, T. (1997) Expression of nm23 protein in pulmonary adenocarcinomas: inverse 1orrelation to tumor progression. Lung Cancer, 17, 103-113. Khan, M.H., Yasuda, M., Higashino, F., Haque, S., Kohgo, T., Nakamura, M. and Shindoh, M. (2001) nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression. Am J Pathol, 158, 1785-1791. Kim, D., Kim, S., Koh, H., Yoon, S.O., Chung, A.S., Cho, K.S. and Chung, J. (2001) Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. Faseb J, 15, 1953-1962. Kimura, N., Shimada, N., Nomura, K. and Watanabe, K. (1990) Isolation and characterization of a cDNA clone encoding rat nucleoside diphosphate kinase. J Biol Chem, 265, 15744-15749. Kimura, Y., Taniguchi, M. and Baba, K. (2002) Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res, 22, 3309-3318. Kino, K., Yamashita, A., Yamaoka, K., Watanabe, J., Tanaka, S., Ko, K., Shimizu, K. and Tsunoo, H. (1989) Isolation and characterization of a new immunomodulatory protein, ling zhi-8 (LZ-8), from Ganoderma lucidium. J Biol Chem, 264, 472-478. Ko, J.L., Hsu, C.I., Lin, R.H., Kao, C.L. and Lin, J.Y. (1995) A new fungal immunomodulatory protein, FIP-fve isolated from the edible mushroom, Flammulina velutipes and its complete amino acid sequence. Eur J Biochem, 228, 244-249. Ko, L.J. and Prives, C. (1996) p53: puzzle and paradigm. Genes Dev, 10, 1054-1072. Kogan, E.A., Shvets, S.I., Kovalenko, V.L. and Soboleva Iu, V. (2004) [Correlation of proliferation, apoptosis, angiogenesis and metastasizing in various histogenetic types of pulmonary cancer (an immunohistochemical investigation)]. Arkh Patol, 66, 33-38. Krebs, H.A. and Hems, R. (1953) Some reactions of adenosine and inosine phosphates in animal tissues. Biochim Biophys Acta, 12, 172-180. Kubiatowski, T., Jang, T., Lachyankar, M.B., Salmonsen, R., Nabi, R.R., Quesenberry, P.J., Litofsky, N.S., Ross, A.H. and Recht, L.D. (2001) Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas. J Neurosurg, 95, 480-488. Kugler, A. (1999) Matrix metalloproteinases and their inhibitors. Anticancer Res, 19, 1589-1592. Labianca, R., Beretta, G., Gatta, G., de Braud, F. and Wils, J. (2004) Colon cancer. Crit Rev Oncol Hematol, 51, 145-170. Lai, W.W., Wu, M.H., Yan, J.J. and Chen, F.F. (1996) Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases. Ann Thorac Surg, 62, 1500-1504. Lejeune, F.J., Ruegg, C. and Lienard, D. (1998) Clinical applications of TNF-alpha in cancer. Curr Opin Immunol, 10, 573-580. Leone, A., Flatow, U., VanHoutte, K. and Steeg, P.S. (1993) Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene, 8, 2325-2333. Liabakk, N.B., Talbot, I., Smith, R.A., Wilkinson, K. and Balkwill, F. (1996) Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res, 56, 190-196. Lieber, M., Smith, B., Szakal, A., Nelson-Rees, W. and Todaro, G. (1976) A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer, 17, 62-70. Lin, J.M., Lin, C.C., Chiu, H.F., Yang, J.J. and Lee, S.G. (1993) Evaluation of the anti-inflammatory and liver-protective effects of anoectochilus formosanus, ganoderma lucidum and gynostemma pentaphyllum in rats. Am J Chin Med, 21, 59-69. Lin, J.Y., Lin, Y.J., Chen, C.C., Wu, H.L., Shi, G.Y. and Jeng, T.W. (1974) Cardiotoxic protein from edible mushrooms. Nature, 252, 235-237. Lin, W.H., Hung, C.H., Hsu, C.I. and Lin, J.Y. (1997) Dimerization of the N-terminal amphipathic alpha-helix domain of the fungal immunomodulatory protein from Ganoderma tsugae (Fip-gts) defined by a yeast two-hybrid system and site-directed mutagenesis. J Biol Chem, 272, 20044-20048. Liotta, L.A., Steeg, P.S. and Stetler-Stevenson, W.G. (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-336. Liu, Y.B., Gao, S.L., Chen, X.P., Peng, S.Y., Fang, H.Q., Wu, Y.L., Peng, C.H., Tang, Z., Xu, B., Wang, J.W., Deng, G.L., Li, H.J., Feng, X.D. and Qian, H.R. (2005) Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma. World J Gastroenterol, 11, 1378-1381. Lo, C.H., Lee, S.C., Wu, P.Y., Pan, W.Y., Su, J., Cheng, C.W., Roffler, S.R., Chiang, B.L., Lee, C.N., Wu, C.W. and Tao, M.H. (2003) Antitumor and antimetastatic activity of IL-23. J Immunol, 171, 600-607. Loercher, A., Lee, T.L., Ricker, J.L., Howard, A., Geoghegen, J., Chen, Z., Sunwoo, J.B., Sitcheran, R., Chuang, E.Y., Mitchell, J.B., Baldwin, A.S., Jr. and Van Waes, C. (2004) Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res, 64, 6511-6523. Ludes-Meyers, J.H., Subler, M.A., Shivakumar, C.V., Munoz, R.M., Jiang, P., Bigger, J.E., Brown, D.R., Deb, S.P. and Deb, S. (1996) Transcriptional activation of the human epidermal growth factor receptor promoter by human p53. Mol Cell Biol, 16, 6009-6019. Madlener, M., Parks, W.C. and Werner, S. (1998) Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res, 242, 201-210. Martini, N., Bains, M.S., Burt, M.E., Zakowski, M.F., McCormack, P., Rusch, V.W. and Ginsberg, R.J. (1995) Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg, 109, 120-129. Metcalfe, A.M., Dixon, R.M. and Radda, G.K. (1997) Wild-type but not mutant p53 activates the hepatocyte growth factor/scatter factor promoter. Nucleic Acids Res, 25, 983-986. Min, B.S., Gao, J.J., Hattori, M., Lee, H.K. and Kim, Y.H. (2001) Anticomplement activity of terpenoids from the spores of Ganoderma lucidum. Planta Med, 67, 811-814. Miyasaka, N., Inoue, H., Totsuka, T., Koike, R., Kino, K. and Tsunoo, H. (1992) An immunomodulatory protein, Ling Zhi-8, facilitates cellular interaction through modulation of adhesion molecules. Biochem Biophys Res Commun, 186, 385-390. Mochizuki, Y., Nakanishi, H., Kodera, Y., Ito, S., Yamamura, Y., Kato, T., Hibi, K., Akiyama, S., Nakao, A. and Tatematsu, M. (2004) TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Clin Exp Metastasis, 21, 39-47. Moses, M.A., Harper, J. and Fernandez, C.A. (2004) A role for antiangiogenic therapy in breast cancer. Curr Oncol Rep, 6, 42-48. Mouridsen, H.T. (2004) Aromatase inhibitors in advanced breast cancer. Semin Oncol, 31, 3-8. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M.E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S.N., Barrera, J.L., Mohar, A., Verastegui, E. and Zlotnik, A. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature, 410, 50-56. Murphy, G., Reynolds, J.J. and Hembry, R.M. (1989) Metalloproteinases and cancer invasion and metastasis. Int J Cancer, 44, 757-760. Nagase, H. (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem, 378, 151-160. Naruke, T., Goya, T., Tsuchiya, R. and Suemasu, K. (1988) Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg, 96, 440-447. Nelson, A.R., Fingleton, B., Rothenberg, M.L. and Matrisian, L.M. (2000) Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol, 18, 1135-1149. Niitsu, N., Okabe-Kado, J., Okamoto, M., Takagi, T., Yoshida, T., Aoki, S., Hirano, M. and Honma, Y. (2001) Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma. Blood, 97, 1202-1210. Nosho, K., Yamamoto, H., Adachi, Y., Endo, T., Hinoda, Y. and Imai, K. (2005) Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis. Br J Cancer, 92, 1193-1200. Ohba, K., Miyata, Y., Koga, S., Kanda, S. and Kanetake, H. (2005) Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2. Urology, 65, 1029-1034. Ohta, Y., Nozawa, H., Tanaka, Y., Oda, M. and Watanabe, Y. (2000) Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer. J Thorac Cardiovasc Surg, 119, 804-813. Osteen, K.G., Yeaman, G.R. and Bruner-Tran, K.L. (2003) Matrix metalloproteinases and endometriosis. Semin Reprod Med, 21, 155-164. Overall, C.M. and Lopez-Otin, C. (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer, 2, 657-672. Ozeki, Y., Takishima, K. and Mamiya, G. (1994) Immunohistochemical analysis of nm23/NDP kinase expression in human lung adenocarcinoma: association with tumor progression in Clara cell type. Jpn J Cancer Res, 85, 840-846. Palanki, M.S. (2002) Inhibitors of AP-1 and NF-kappa B mediated transcriptional activation: therapeutic potential in autoimmune diseases and structural diversity. Curr Med Chem, 9, 219-227. Pan, L., Eckhoff, C. and Brinckerhoff, C.E. (1995) Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs. J Cell Biochem, 57, 575-589. Pan, M.R. and Hung, W.C. (2002) Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription. J Biol Chem, 277, 32775-32780. Park, B.K., Zeng, X. and Glazer, R.I. (2001) Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. Cancer Res, 61, 7647-7653. Partanen, R., Koskinen, H. and Hemminki, K. (1995) Tumour necrosis factor-alpha (TNF-alpha) in patients who have asbestosis and develop cancer. Occup Environ Med, 52, 316-319. Patocka, J. (1999) Anti-inflammatory triterpenoids from mysterious mushroom Ganoderma lucidum and their potential possibility in modern medicine. Acta Medica (Hradec Kralove), 42, 123-125. Philip, S., Bulbule, A. and Kundu, G.C. (2001) Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J Biol Chem, 276, 44926-44935. Philips, N., Keller, T. and Gonzalez, S. (2004) TGF beta-like regulation of matrix metalloproteinases by anti-transforming growth factor-beta, and anti-transforming growth factor-beta1 antibodies in dermal fibroblasts: Implications for wound healing. Wound Repair Regen, 12, 53-59. Price, J.E. (1986) Clonogenicity and experimental metastatic potential of spontaneous mouse mammary neoplasms. J Natl Cancer Inst, 77, 529-535. Rosengard, A.M., Krutzsch, H.C., Shearn, A., Biggs, J.R., Barker, E., Margulies, I.M., King, C.R., Liotta, L.A. and Steeg, P.S. (1989) Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature, 342, 177-180. Salerno, M., Palmieri, D., Bouadis, A., Halverson, D. and Steeg, P.S. (2005) Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells. Mol Cell Biol, 25, 1379-1388. Shaheen, R.M., Davis, D.W., Liu, W., Zebrowski, B.K., Wilson, M.R., Bucana, C.D., McConkey, D.J., McMahon, G. and Ellis, L.M. (1999) Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. Cancer Res, 59, 5412-5416. Shan, B., Zhuo, Y., Chin, D., Morris, C.A., Morris, G.F. and Lasky, J.A. (2005) Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells. J Biol Chem, 280, 1103-1111. Shapiro, S.D., Kobayashi, D.K. and Welgus, H.G. (1992) Identification of TIMP-2 in human alveolar macrophages. Regulation of biosynthesis is opposite to that of metalloproteinases and TIMP-1. J Biol Chem, 267, 13890-13894. Shimizu, A., Yano, T., Saito, Y. and Inada, Y. (1985) Isolation of an inhibitor of platelet aggregation from a fungus, Ganoderma lucidum. Chem Pharm Bull (Tokyo), 33, 3012-3015. Shiraishi, K., Fukuda, S., Mori, T., Matsuda, K., Yamaguchi, T., Tanikawa, C., Ogawa, M., Nakamura, Y. and Arakawa, H. (2000) Identification of fractalkine, a CX3C-type chemokine, as a direct target of p53. Cancer Res, 60, 3722-3726. Silletti, S., Yebra, M., Perez, B., Cirulli, V., McMahon, M. and Montgomery, A.M. (2004) Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J Biol Chem, 279, 28880-28888. Sparano, J.A., Gray, R., Giantonio, B., O''Dwyer, P. and Comis, R.L. (2004) Evaluating antiangiogenesis agents in the clinic: the Eastern Cooperative Oncology Group Portfolio of Clinical Trials. Clin Cancer Res, 10, 1206-1211. Steeg, P.S., Bevilacqua, G., Kopper, L., Thorgeirsson, U.P., Talmadge, J.E., Liotta, L.A. and Sobel, M.E. (1988) Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst, 80, 200-204. Talmadge, J.E., Phillips, H., Schneider, M., Rowe, T., Pennington, R., Bowersox, O. and Lenz, B. (1988) Immunomodulatory properties of recombinant murine and human tumor necrosis factor. Cancer Res, 48, 544-550. Tomita, M., Ayabe, T., Matsuzaki, Y. and Onitsuka, T. (2001) Expression of nm23-H1 gene product in mediastinal lymph nodes from lung cancer patients. Eur J Cardiothorac Surg, 19, 904-907. Urano, T., Takamiya, K., Furukawa, K. and Shiku, H. (1992) Molecular cloning and functional expression of the second mouse nm23/NDP kinase gene, nm23-M2. FEBS Lett, 309, 358-362. van der Hem, L.G., van der Vliet, J.A., Bocken, C.F., Kino, K., Hoitsma, A.J. and Tax, W.J. (1995) Ling Zhi-8: studies of a new immunomodulating agent. Transplantation, 60, 438-443. Vojta, P.J. and Barrett, J.C. (1995) Genetic analysis of cellular senescence. Biochim Biophys Acta, 1242, 29-41. Wallet, V., Mutzel, R., Troll, H., Barzu, O., Wurster, B., Veron, M. and Lacombe, M.L. (1990) Dictyostelium nucleoside diphosphate kinase highly homologous to Nm23 and Awd proteins involved in mammalian tumor metastasis and Drosophila development. J Natl Cancer Inst, 82, 1199-1202. Wang, S.Y., Hsu, M.L., Hsu, H.C., Tzeng, C.H., Lee, S.S., Shiao, M.S. and Ho, C.K. (1997) The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer, 70, 699-705. Wang, X., Mori, T., Jung, J.C., Fini, M.E. and Lo, E.H. (2002a) Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase. J Neurotrauma, 19, 615-625. Wang, Y.Y., Khoo, K.H., Chen, S.T., Lin, C.C., Wong, C.H. and Lin, C.H. (2002b) Studies on the immuno-modulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities. Bioorg Med Chem, 10, 1057-1062. Webb, C.P., Taylor, G.A., Jeffers, M., Fiscella, M., Oskarsson, M., Resau, J.H. and Vande Woude, G.F. (1998) Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasis. Oncogene, 17, 2019-2025. Welch, D.R., Sakamaki, T., Pioquinto, R., Leonard, T.O., Goldberg, S.F., Hon, Q., Erikson, R.L., Rieber, M., Rieber, M.S., Hicks, D.J., Bonventre, J.V. and Alessandrini, A. (2000) Transfection of constitutively active mitogen-activated protein/extracellular signal-regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells. Cancer Res, 60, 1552-1556. Westermarck, J. and Kahari, V.M. (1999) Regulation of matrix metalloproteinase expression in tumor invasion. Faseb J, 13, 781-792. Yang, T.T. and Hawkes, S.P. (1992) Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc Natl Acad Sci U S A, 89, 10676-10680. Yasunari, K., Kohno, M., Hasuma, T., Horio, T., Kano, H., Yokokawa, K., Minami, M. and Yoshikawa, J. (1997) Dopamine as a novel antimigration and antiproliferative factor of vascular smooth muscle cells through dopamine D1-like receptors. Arterioscler Thromb Vasc Biol, 17, 3164-3173. Yoon, S.O., Kim, M.M. and Chung, A.S. (2001) Inhibitory effect of selenite on invasion of HT1080 tumor cells. J Biol Chem, 276, 20085-20092. Yoshida, M., Korfhagen, T.R. and Whitsett, J.A. (2001) Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways. J Immunol, 166, 7514-7519. Zarovni, N., Monaco, L. and Corti, A. (2004) Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor alpha coupled to NGR and RGD tumor-homing peptides. Hum Gene Ther, 15, 373-382. Zhang, G.L., Wang, Y.H., Ni, W., Teng, H.L. and Lin, Z.B. (2002a) Hepatoprotective role of Ganoderma lucidum polysaccharide against BCG-induced immune liver injury in mice. World J Gastroenterol, 8, 728-733. Zhang, Y., Thant, A.A., Machida, K., Ichigotani, Y., Naito, Y., Hiraiwa, Y., Senga, T., Sohara, Y., Matsuda, S. and Hamaguchi, M. (2002b) Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90. Cancer Res, 62, 3962-3965. Zheng, C.L., Wen, J.F. and Huang, Y. (2005) [Expression and significance of PTEN and nm23 in the metastasis of gallbladder cancer]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 30, 46-48. Zollo, M., Andre, A., Cossu, A., Sini, M.C., D''Angelo, A., Marino, N., Budroni, M., Tanda, F., Arrigoni, G. and Palmieri, G. (2005) Overexpression of h-prune in breast cancer is correlated with advanced disease status. Clin Cancer Res, 11, 199-205.
|